The bio and pharmaceutical industries are trying to dismantle the vital but little known 340B drug discount program.
An op-ed in The Hill last Tuesday called on our country to arm our healthcare system with new weapons to combat...
A recent entry in the Congress Blog suggested that the Centers for Medicare and Medicaid Services' (CMS) efforts to standardize assessment data was based on a goal of “….creating a functional measurement tool that could be used throughout the industry.”
Food safety has always been an issue (in China), due to lack of knowledge about hygiene standards.
Six million fewer young children will die this year than in 1990, when an unimaginable 12.6 million children worldwide died before reaching their fifth birthday.
Large increases in premiums aren’t new. There is a long history of significant rate increases, even double-digit rate increases in the individual market.
Autism Spectrum Disorder has increased dramatically in the last 25 years. It is a crisis. What will legislators do with a federal program which, after eight years and $1.7 billion, has failed to truly address this crisis? Sadly...
The administration erred in its decision not to allow young immigrants granted Deferred Action for Childhood Arrivals (DACA) to enroll in ObamaCare.
Policy should never get ahead of science.
Perhaps the greatest shortcoming of the data is the failure to completely disclose the difference in costs between physicians’ offices and hospitals.